LYTIR

Company · RGNX

REGENXBIO Inc.

Nasdaq's symbol directory lists RGNX on Nasdaq as “REGENXBIO Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 2 occasions ($949K); insiders sold on 3 occasions ($718K); 2 filings by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $949K in total; Insider sales: $718K in total.Jun: Insider sales $216KJul: Insider sales $502KAug: Insider purchases $949KDecJanFebMarAprMayJunJulAugSepOctNov$949K$502K
Insider purchases above the line: $949KInsider sales below: $718K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Ciongoli Gregory Austin bought on 2 days latest Aug 27, 2026 bought $949K
  2. PAKOLA STEVE, Chief Medical Officer sold on 3 days all under a 10b5-1 plan latest Jul 2, 2026 sold $718K
Every trade (5)
  1. BUYCiongoli Gregory Austin bought Aug 27, 2026 53,407 shares filing $500K
  2. BUYCiongoli Gregory Austin bought Aug 26, 2026 49,196 shares filing $450K
  3. SELLPAKOLA STEVE, Chief Medical Officer sold Jul 2, 2026 2,161 shares 10b5-1 plan (scheduled) filing $29K
  4. SELLPAKOLA STEVE, Chief Medical Officer sold Jul 1, 2026 36,725 shares 10b5-1 plan (scheduled) filing $472K
  5. SELLPAKOLA STEVE, Chief Medical Officer sold Jun 29, 2026 19,608 shares 10b5-1 plan (scheduled) filing $216K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. STATE STREET CORPORATION filed Nov 10, 2026 Schedule 13G passive 3,153,366 shares filing 4.8%
  2. JPMORGAN CHASE & CO. filed Oct 13, 2026 Schedule 13G passive 3,560,915 shares filing 5.3%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Departure or appointment of directors or officers filing Oct 16, 2026
  3. Entry into a material definitive agreement filing Sep 23, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.